quant Small Cap Fund - Growth - Regular Plan
₹267.6358
₹1.19 (-0.44%)
NAV as of 29 May 2026
Today's NAV — all variants
Regular · Growth
₹₹267.6358
₹1.19 (-0.44%)
29 May 2026
AMFI: 100177
Direct · Growth
₹₹292.9274
₹1.29 (-0.44%)
29 May 2026
AMFI: 120828
Regular · IDCW
₹₹212.8384
₹0.94 (-0.44%)
29 May 2026
AMFI: 100176
Direct · IDCW
₹₹228.9789
₹1.01 (-0.44%)
29 May 2026
AMFI: 120827
Returns (Lumpsum)
CAGR for periods ≥ 1 yearSIP Returns (XIRR)
₹1,000/month SIP, annualisedSIP since inception — what ₹500/month became
Real NAV backtest from day one
₹1,77,000
Invested
₹22,06,133
Value today
15.1%
XIRR (p.a.)
₹500/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹26,882
Value today
11.8%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹10L corpus with ₹5,000/month withdrawals since inception
Corpus is still growing despite monthly payouts
₹10,00,000
Initial corpus
₹17,70,000
Withdrawn
₹48,21,051
Corpus left
+₹55,91,051 net gain — withdrew ₹17,70,000 AND corpus grew
Plan your SWP with real NAV₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹1,61,29,428
Value today
+0.0%
vs lumpsum
STP beat direct lumpsum by 0.0% — reduced timing risk paid off
Model your own STP with real NAVBeat the benchmark — ₹500/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹22,06,133
Benchmark
₹18,31,239
+₹3,74,894 extra wealth vs the benchmark index
Backtest this SIP yourself₹1 lakh on the worst crash day — 22 Mar 2020
Worst single-day Nifty drop during this fund's life
₹1,00,000
Invested
₹9,43,755
Value today
9.4×
Multiple
Staying invested through that crash turned ₹1L into ₹9,43,755 — a 9.4× return
Read: Staying invested through crashesDirect vs Regular — ₹500/month over 10 years
Expense ratio drag on your actual returns
Direct plan
₹2,28,700
Regular plan
₹2,13,842
Direct earns ₹14,858 more on a ₹60K investment — 2.48% extra return per year
Same fund, same NAV history — only the expense ratio differs. Direct plans always outperform Regular over time.
Learn about Direct vs Regular plansFund Details
Risk Metrics
Trailing 1 year, annualised-0.40
Sharpe Ratio
-0.03
Alpha
0.46
Beta
-0.39
Sortino
17.32%
Std Dev
-22.00%
Max Drawdown
Portfolio Holdings
Top 50 holdings · as of Apr 2026
| Security | % NAV |
|---|---|
Reliance Industries Limited INE002A01018 | 9.47% |
RBL Bank Limited INE976G01028 | 4.75% |
Adani Power Limited INE814H01029 | 4.38% |
HFCL Limited INE548A01028 | 3.44% |
SUN TV Network Limited INE424H01027 | 2.92% |
Piramal Finance Ltd INE202B01038 | 2.85% |
Anand Rathi Wealth Limited INE463V01026 | 2.81% |
Aster DM Healthcare Limited INE914M01019 | 2.61% |
Adani Green Energy Limited INE364U01010 | 2.20% |
Adani Enterprises Limited INE423A01024 | 2.19% |
Poly Medicure Limited INE205C01021 | 2.17% |
Arvind Limited INE034A01011 | 1.94% |
Bikaji Foods International Limited INE00E101023 | 1.93% |
Capri Global Capital Limited INE180C01042 | 1.93% |
Aegis Logistics Limited INE208C01025 | 1.84% |
Welspun Corp Limited INE191B01025 | 1.80% |
ICICI Bank Limited INE090A01021 | 1.77% |
Ventive Hospitality Limited INE781S01027 | 1.72% |
Bayer Cropscience Ltd INE462A01022 | 1.63% |
Sequent Scientific Limited INE807F01027 | 1.61% |
Usha Martin Limited INE228A01035 | 1.59% |
Zydus Wellness Ltd INE768C01028 | 1.51% |
National Building Construction Corp INE095N01031 | 1.48% |
Manappuram Finance Ltd INE522D01027 | 1.44% |
Pfizer Ltd INE182A01018 | 1.42% |
Aditya Birla Lifestyle Brands Limited INE14LE01019 | 1.35% |
Karnataka Bank Ltd INE614B01018 | 1.30% |
Strides Pharma Science Ltd INE939A01011 | 1.23% |
Welspun Enterprises Limited INE625G01013 | 1.16% |
Samvardhana Motherson International Ltd INE775A01035 | 1.06% |
Marathon Nextgen Realty Limited INE182D01020 | 1.04% |
NCC Ltd INE868B01028 | 0.93% |
ANTHEM BIOSCIENCES LIMITED INE0CZ201020 | 0.92% |
Jubilant Pharmova Limited INE700A01033 | 0.90% |
KEYSTONE REALTORS LIMITED INE263M01029 | 0.80% |
Gland Pharma Limited INE068V01023 | 0.79% |
JM FINANCIAL LIMITED INE780C01023 | 0.77% |
EID Parry (India) Ltd INE126A01031 | 0.76% |
Afcons Infrastructure Limited INE101I01011 | 0.74% |
Orchid Pharma Limited INE191A01027 | 0.71% |
Just Dial Limited INE599M01018 | 0.65% |
Black Box Limited INE676A01027 | 0.62% |
Alivus Life Sciences INE03Q201024 | 0.60% |
EPL Limited INE255A01020 | 0.59% |
IRB Infrastructure Developers Limited INE821I01022 | 0.52% |
Welspun Living Limited INE192B01031 | 0.51% |
TVS Srichakra Limited INE421C01016 | 0.48% |
Minda Corporation Ltd INE842C01021 | 0.47% |
| Security | % NAV |
|---|---|
Aurobindo Pharma Limited 26/05/2026 AUROPHARMA260526 | 1.90% |
RBL Bank Limited 26/05/2026 RBLBANK260526 | 1.02% |
Performance Comparison
Interested in This Fund?
Our experts will help you decide if this fund fits your goals.
Investment Objective
quant Small Cap Fund - Growth - Regular Plan aims to generate long-term capital appreciation by investing in small-cap companies — ranked 251st and below by market capitalisation. Small-cap funds offer higher growth potential but also carry higher volatility and risk compared to large-cap and mid-cap funds.
About This Fund
quant Small Cap Fund - Growth - Regular Plan is a Small Cap mutual fund offered by quant Mutual Fund. The fund has been operational for over 29 years. It manages assets worth ₹27,712 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY SMALLCAP 250 TRI. The current expense ratio is 1.64%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •Investors who understand that small-cap stocks can be highly volatile and are willing to stay invested for the long term
- •SIP investors who can benefit from rupee cost averaging during market fluctuations